Perham Gorji will speaking on the panel, “FDA Enforcement in Transition: Tools, Trends, and Practical Exposure Across the Product Lifecycle,” discussing:
- Key trends shaping FDA enforcement strategy, including the impact of agency reorganization and shifting priorities
- FDA’s enforcement toolkit and how it is currently being deployed, including warning letters, untitled letters, import alerts, and administrative and judicial actions
- Inspectional dynamics and risk areas, including remote oversight tools, foreign inspections, and promotional surveillance
- The intersection of FDA enforcement with DOJ activity, including criminal investigations, qui tam actions, and civil fraud/safety-based resolutions